Virtual Medicinal Product (VMP) - Ondansetron 4mg/2ml solution for injection ampoules

Name Details

Name Start Date End Date
Name Current Name Ondansetron 4mg/2ml solution for injection ampoules Start Date 21-01-2009 End Date
Previous Name Previous Name Ondansetron 4mg/2ml solution for infusion ampoules Start Date 19-01-2009 End Date 20-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular, Intravenous
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular, solutioninjection.intravenous, solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A04AA01
BNF Start Date End Date
Current BNF 04060000 Start Date 04-04-2022 End Date
Previous BNF 04060000 Start Date 14-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36022411000001102 29-10-2018
322172006 12-03-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Ondansetron hydrochloride dihydrate Based on Base Substance Ondansetron 2 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 ampoule
10 ampoule 2000 Part VIIIA Category C